Objective-To examine the role of peak bone mass and subsequent postmenopausal bone loss in the development of osteoporosis and the reliability of identifying women at risk from one bone mass measurement and one biochemical assessment of the future bone loss.
Objective-To examine the role of peak bone mass and subsequent postmenopausal bone loss in the development of osteoporosis and the reliability of identifying women at risk from one bone mass measurement and one biochemical assessment of the future bone loss.
Design-Population based study. Setting-Outpatient clinic for research into osteoporosis.
Subjects-178 healthy early postmenopausal women who had participated in a two year study in 1977. 154 of the women underwent follow up examination in 1989, of whom 33 were excluded because of diseases or taking drugs known to affect calcium metabolism.
Main outcome measures-Bone mineral content of the forearm and values of biochemical markers of bone turnover.
Results-The average reduction in bone mineral content during 1977-89 was 20%, but the fast losers had lost 10-0% more than had the slow loser group (mean loss 26-6% in fast losers and 16-6% in slow losers; p<0-001). Prediction of future bone mineral content using baseline bone mineral content We conducted a study to assess the validity of biochemical testing shortly after the menopause to estimate the rate of postmenopausal bone loss in the following 12 years. A further aim was to assess the ability of one measurement of bone mass combined with one biochemical screening just after the menopause to predict the bone mass at the age when fractures start to occur.
BMJ VOLUME 303 19 OCTOBER 1991 Subjects and methods One hundred and seventy eight postmenopausal women were recruited to a two year study of bone loss in 1977. 4 The women were aged 45-54 years, had not menstruated for six months to three years, and had no diseases or were not taking drugs known to influence calcium metabolism. 4 In 1989 we invited all the women to a follow up examination. Twenty four women were unable to participate and 154 women (87%) underwent the follow up examination. Of these, 33 women were excluded because of past or present diseases or use of drugs known to influence calcium metabolism.6 This left 121 women in the final study group.
In 1989 we measured the bone mineral content in the forearms by single photon absorptiometry, taking the mean of six scans 4 mm apart just proximal to the site where the distance between the ulna and the radius is 8 mm. The principle was the same as that used in the 1977 study. The long term in vivo precision was about 1%.7 Fasting urinary creatinine, calcium, and hydroxyproline concentrations and serum alkaline phosphatase activity were measured by standard procedures. Radiography of the thoracolumbar spine was performed. The anterior, midvertebral, and posterior heights of each vertebra (T4-L5) were assessed by the same radiologist. Vertebral compression fractures were diagnosed by the method of Melton et al. 8 After adjustment for normal variations in vertebral shape and size compression fracture was considered to be present if the posterior height was at least 15% less than the posterior height of either of the adjacent vertebrae. (E2oe 9iea cnetatr1 yerCie nbok mne strength, the future risk would then be dependent on knowledge in ultimate of the bone mass attained at skeletal maturity (peak [s, decreased bone mass). However, as risk of fracture is so closely sk factor for linked to bone mass, the future risk must depend on ir or even no both the peak bone mass and the bone loss experienced after the peak bone mass has been reached. Our aim some extent was to clarify the individual importance of these two ssessment of factors.
The study population was selected in 1977 as a random sample of the population living in a defined area around Glostrup Hospital. This background population has been shown to be representative of the Danish population.'3 We have shown that the combination of a baseline bone mass measurement at v menopause and biochemical estimation of the future bone loss gives the best prediction of the bone mass in later life when fractures start to occur. This is supported by the 10-0% difference in bone mass between the predicted fast and the slow bone losers 12 years r=0 9 after the menopause, which corresponds with the Y=0 9x + 3 2 difference seen between 65-70 year old women with fractures and those without fractures.'4 Furthermore, the data in figure 4 show that these two diagnostic tests Cross tabulations of live births (grossed up to 100% of live births) and deaths were produced by legitimacy, social class, and birth weight; birth weight was divided into seven categories from < 1500 g to :-4000 g in 500 g increments. The birth weight was specified in over 99.9% of live births.
Only births within marriage were analysed by social class. Based on occupation of father, births and deaths of infants were allocated to one of the six classes, from I (professional) to V (unskilled manual). Infants whose fathers were students or members of the armed forces or whose fathers' occupation was not given or was inadequately described were allocated to the category "other." For births registered outside marriage a distinction was drawn between those registered jointly by the mother and father and those registered solely by the mother.
Infant mortality was divided into neonatal mortality and postneonatal mortality, with postneonatal mortality referring to deaths in infants aged 29 days to 1 year. In both instances death rates were calculated by 964 BMJ VOLUME 303
